Rheumatology international

(ISSN: 0172-8172)

Table of Contents

2015 - 35 (9)

  • Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab. 
  • Dose reduction of biological treatment in patients with axial spondyloarthritis in clinical remission: Are there any differences between patients who relapsed and to those who remained in low disease activity? 
  • How is the experience of pain measured in older, community-dwelling people with osteoarthritis? A systematic review of the literature. 
  • Validation and cross-cultural adaptation of the 'Fibromyalgia Participation Questionnaire' to the Spanish population: study protocol. 
  • Eosinophilic granulomatosis with polyangiitis (EGPA) and PRES: a case-based review of literature in ANCA-associated vasculitides. 
  • Successful treatment of a patient with SAPHO syndrome with certolizumab pegol. 
  • Efficacy of Raynaud's phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review. 
  • Are there racial disparities in utilization and outcomes after total elbow arthroplasty? 
  • Predictors of hospital length of stay in pediatric Henoch-Sch��nlein purpura. 
  • Hierarchical nature of activities of daily living in the Spanish Disability Survey. 
  • A patient-reported outcome measures-based composite index (RAPID3) for the assessment of disease activity in ankylosing spondylitis. 
  • Cost-utility analysis of tocilizumab monotherapy in first line versus standard of care for the treatment of rheumatoid arthritis in Greece. 
  • Serum levels of C-peptide are associated with coronary artery calcification in patients with rheumatoid arthritis. 
  • Increased detection of latent tuberculosis by tuberculin skin test and booster phenomenon in early rheumatoid arthritis patients. 
  • Vitamin D status in Egyptian patients with juvenile-onset systemic lupus erythematosus. 
  • Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience. 
  • Patterns of use and dosing of tocilizumab in the treatment of patients with rheumatoid arthritis in routine clinical practice: the ACT-LIFE study. 
  • Follow-up results of isoniazid chemoprophylaxis during biological therapy in Colombia. 
  • Renal clearance of uric acid is linked to insulin resistance and lower excretion of sodium in gout patients. 
  • Histopathological indicators of disease outcome in class IV lupus nephritis: a revisit of various indices. 
  • Staphylococcus aureus sepsis in rheumatoid arthritis. 
  • Direct and indirect costs associated with ankylosing spondylitis and related disease activity scores in Turkey. 
  • Cross-sectional correlation of single-item health literacy screening questions with established measures of health literacy in patients with rheumatoid arthritis. 
  • Efficacy of certolizumab pegol: a case study in a patient with rheumatoid arthritis on maintenance hemodialysis. 
  • Rituximab-induced remission in a woman with coexisting rheumatoid arthritis and nephrotic syndrome. 
  • Acute treatment-resistant post-partum necrotising myopathy with anti-Ro52/TRIM21 antibodies treated with rituximab. 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.